News Tianjin Development Holdings Limited

Equities

882 HK0882007260

Delayed Hong Kong S.E. Other stock markets 11:33:23 2024-04-24 pm EDT			5-day change	1st Jan Change
1.68 ^HKD	+1.82%		+2.44%	+14.29%

Mar. 27	Tianjin Development’s Chairman Steps Down; Successor Named	MT
Mar. 27	Tianjin Development Holdings Limited Announces Board Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tianjin Development’s Chairman Steps Down; Successor Named	Mar. 27	MT
Tianjin Development Holdings Limited Announces Board Changes	Mar. 27	CI
Tianjin Development Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 29 July 2024	Mar. 27	CI
Tianjin Development Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	Mar. 22	MT
Tianjin Development Holdings Expects Up to 80% Jump in 2023 Profit	Mar. 14	MT
Tianjin Development Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	Mar. 13	CI
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	Jan. 02	MT
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	Dec. 14	MT
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	Dec. 12	MT
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	Nov. 10	MT
Tianjin Development Holdings Limited Announces Board Changes	23-09-29	CI
Tianjin Development Holdings Limited(SEHK:882) dropped from S&P Global BMI Index	23-09-18	CI
Tianjin Development Holdings' H1 Attributable Profit Grows	23-08-30	MT
Tianjin Development Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2023, Payable on 30 October 2023	23-08-30	CI
Tianjin Development Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	23-08-24	MT
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	23-08-02	MT
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	23-07-26	MT
Tianjin Development Holdings Limited Approves Final Dividend	23-06-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Tianjin Development Holdings Limited

Equities

882

HK0882007260

Summary

Filters